Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study.

[1]  S. Allahverdian,et al.  Serum lipid levels in an Iranian population of children and adolescents: Tehran lipid and glucose study , 2004, European Journal of Epidemiology.

[2]  G. Reaven.  The insulin resistance syndrome , 2003, Current atherosclerosis reports.

[3]  F. Azizi,et al.  Determinants of serum HDL-C level in a Tehran urban population: the Tehran Lipid and Glucose Study. , 2002, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[4]  W. Dietz,et al.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. , 2002, JAMA.

[5]  L. Groop,et al.  The metabolic syndrome influences the risk of chronic complications in patients with Type II diabetes , 2001, Diabetologia.

[6]  L. Groop,et al.  Cardiovascular morbidity and mortality associated with the metabolic syndrome. , 2001, Diabetes care.

[7]  C. Bogardus,et al.  Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development. , 2001, Diabetes care.

[8]  J. Meigs,et al.  Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. , 2000, American journal of epidemiology.

[9]  Fereidoun Azizi,et al.  Tehran Lipid and Glucose Study (TLGS): rationale and design , 2000 .

[10]  Wei Chen,et al.  Age-related patterns of the clustering of cardiovascular risk variables of syndrome X from childhood to young adulthood in a population made up of black and white subjects: the Bogalusa Heart Study. , 2000, Diabetes.

[11]  P. Björntorp.  Neuroendocrine perturbations as a cause of insulin resistance , 1999, Diabetes/metabolism research and reviews.

[12]  J. Little,et al.  Plasma lipids and lipoprotein reference values, and the prevalence of dyslipoproteinemia in Canadian adults. Canadian Heart Health Surveys Research Group. , 1999, Canadian Journal of Cardiology.

[13]  K. Greenlund,et al.  Prevalence and correlates of the insulin resistance syndrome among Native Americans. The Inter-Tribal Heart Project. , 1999, Diabetes care.

[14]  A. Rantala,et al.  Prevalence of the metabolic syndrome in drug‐treated hypertensive patients and control subjects , 1999, Journal of internal medicine.

[15]  M. Trevisan,et al.  Syndrome X and mortality: a population-based study. Risk Factor and Life Expectancy Research Group. , 1998, American journal of epidemiology.

[16]  S. Kiechl,et al.  Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. , 1998, Diabetes.

[17]  M. Amar,et al.  The role of hepatic lipase in lipoprotein metabolism and atherosclerosis , 1998 .

[18]  Ralph B D'Agostino,et al.  Risk Variable Clustering in the Insulin Resistance Syndrome: The Framingham Offspring Study , 1997, Diabetes.

[19]  A. Dobson,et al.  Declining rates of coronary heart disease in New Zealand and Australia, 1983-1993. , 1997, American journal of epidemiology.

[20]  R. D'Agostino,et al.  Sex and time trends in cardiovascular disease incidence and mortality: the Framingham Heart Study, 1950-1989. , 1996, American journal of epidemiology.

[21]  G. Reaven,et al.  Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system. , 1996, The New England journal of medicine.

[22]  E. Boyko,et al.  Visceral Adiposity, Fasting Plasma Insulin, and Blood Pressure in Japanese-Americans , 1995, Diabetes Care.

[23]  J. Després,et al.  Relation of components of insulin resistance syndrome to coronary disease risk. , 1994, Current opinion in lipidology.

[24]  G. Mcclearn,et al.  Genetic and environmental influences on serum lipid levels in twins. , 1993, The New England journal of medicine.

[25]  M. Taskinen.  Hyperinsulinism and dyslipidemias as coronary heart disease risk factors in NIDDM. , 1993, Advances in experimental medicine and biology.

[26]  A. Onat,et al.  Plasma lipids and their interrelationship in Turkish adults. , 1992, Journal of epidemiology and community health.

[27]  V. Pollock,et al.  Fasting serum insulin levels in essential hypertension. A meta-analysis. , 1992, Archives of internal medicine.

[28]  P. Zimmet.  Kelly West Lecture 1991 Challenges in Diabetes Epidemiology—From West to the Rest , 1992, Diabetes Care.

[29]  A. Tall,et al.  Serum lipoprotein lipid concentration and composition in homozygous and heterozygous patients with cholesteryl ester transfer protein deficiency. , 1991, Atherosclerosis.

[30]  R. DeFronzo,et al.  Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease , 1991, Diabetes Care.

[31]  P. Björntorp.  "Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. , 1990, Arteriosclerosis.

[32]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[33]  B. Lewis,et al.  Blood lipid concentrations and other cardiovascular risk factors: distribution, prevalence, and detection in Britain , 1988, British medical journal.

[34]  K. Namboodiri,et al.  Biological and cultural sources of familial resemblance in plasma lipids: A comparison between North America and Israel—the lipid research clinics program , 1988, Genetic epidemiology.

[35]  S B Hulley,et al.  Risk factors for coronary heart disease in adult female twins. Genetic heritability and shared environmental influences. , 1987, American journal of epidemiology.

[36]  D. Jacobs,et al.  Lipoprotein‐Cholesterol Distributions in Selected North American Populations: The Lipid Research Clinics Program Prevalence Study , 1980, Circulation.

[37]  P. Davidson,et al.  Insulin resistance in hyperglyceridemia. , 1965, Metabolism: clinical and experimental.

[38]  J. Meigs,et al.  THE RELATIONSHIP BETWEEN SERUM TRIGLYCERIDES AND SKINFOLD THICKNESS IN OBESE SUBJECTS * , 1965, Annals of the New York Academy of Sciences.

[39]  栗原 登,et al.  Trends cancer mortality for selected sites in 24 countries , 1960 .